ADCILIB 100MG

Adcilib 100mg Capsule is a targeted therapy that contains the active ingredient palbociclib. This medication falls under the category of anticancer drugs known as cyclin-dependent kinase inhibitors. It is utilized in the treatment of hormone receptor-positive, human epidermal growth factor 2 negative advanced or metastatic breast cancer, which has spread to other areas of the body. Cancer is characterized by the uncontrolled and abnormal proliferation of cells. This capsule is administered alongside certain other anticancer treatments.

Common side effects associated with Adcilib 100mg Capsule may include nausea, vomiting, diarrhea, fatigue, hair loss, dry skin, rashes, infections, nosebleeds, reduced appetite, low blood cell counts, swelling of the lips and mouth, alterations in taste, dry eyes, blurred vision, and increased tearing. If any of these side effects are bothersome or persist, please inform your doctor.

If you have an allergy to Adcilib 100mg Capsule or any of its components, notify your healthcare provider. It is crucial to inform your doctor of any signs of infection (such as fever, chills, or sore throat), liver issues, kidney problems, or intolerance to certain sugars before starting this medication. Seek immediate medical attention if you experience symptoms like a dry cough, chest pain, or difficulty breathing, as these may indicate lung inflammation.

Ensure that you inform your physician about all medications you are taking, including supplements and herbal products, prior to beginning treatment with this drug. It is important to use effective birth control during treatment and for at least three weeks following the last dose. This medication is not recommended for adolescents and children under the age of 18.